SNALP-siApob

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSNALP-siApob
Drug Alias Nameapolipoprotein B-targeting siRNA duplexes (SNALP, hyperlipidemia) (J&J PRD)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionApolipoprotein B-100 inhibitors
TargetsApolipoprotein B-100
Therapy Area/IndicationsHyperlipidemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
Active IndicationsN/A
Inactive IndicationsHyperlipidemias

Other Information

ATC CodeN/A
Related LinksN/A